Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Women 50 years or younger with endometrial cancer: the argument for universal mismatch repair screening and potential for targeted therapeutics.

Ring KL, Connor EV, Atkins KA, Ricketts W, Kashlan B, Modesitt SC.

Int J Gynecol Cancer. 2013 Jun;23(5):853-60. doi: 10.1097/IGC.0b013e31828eed9c.

PMID:
23552806
2.

Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and younger.

Shih KK, Garg K, Levine DA, Kauff ND, Abu-Rustum NR, Soslow RA, Barakat RR.

Gynecol Oncol. 2011 Oct;123(1):88-94. doi: 10.1016/j.ygyno.2011.06.005. Epub 2011 Jul 13.

PMID:
21742371
3.

Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.

Garg K, Shih K, Barakat R, Zhou Q, Iasonos A, Soslow RA.

Am J Surg Pathol. 2009 Dec;33(12):1869-77. doi: 10.1097/PAS.0b013e3181bc9866.

PMID:
19898223
4.

DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers.

Kato M, Takano M, Miyamoto M, Sasaki N, Goto T, Tsuda H, Furuya K.

J Gynecol Oncol. 2015 Jan;26(1):40-5. doi: 10.3802/jgo.2015.26.1.40. Epub 2014 Oct 13.

5.

Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.

Buchanan DD, Tan YY, Walsh MD, Clendenning M, Metcalf AM, Ferguson K, Arnold ST, Thompson BA, Lose FA, Parsons MT, Walters RJ, Pearson SA, Cummings M, Oehler MK, Blomfield PB, Quinn MA, Kirk JA, Stewart CJ, Obermair A, Young JP, Webb PM, Spurdle AB.

J Clin Oncol. 2014 Jan 10;32(2):90-100. doi: 10.1200/JCO.2013.51.2129. Epub 2013 Dec 9.

6.

Clinical and pathologic features of young endometrial cancer patients with loss of mismatch repair expression.

Grzankowski KS, Shimizu DM, Kimata C, Black M, Terada KY.

Gynecol Oncol. 2012 Sep;126(3):408-12. doi: 10.1016/j.ygyno.2012.05.019. Epub 2012 May 20.

PMID:
22617524
7.

Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variables.

Joehlin-Price AS, Perrino CM, Stephens J, Backes FJ, Goodfellow PJ, Cohn DE, Suarez AA.

Gynecol Oncol. 2014 Apr;133(1):43-7. doi: 10.1016/j.ygyno.2014.01.017. Epub 2014 Jan 17.

8.

Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.

Mills AM, Liou S, Ford JM, Berek JS, Pai RK, Longacre TA.

Am J Surg Pathol. 2014 Nov;38(11):1501-9. doi: 10.1097/PAS.0000000000000321.

9.

[Expression of MMR in endometrial adenocarcinoma in women under 50 years old].

Wu HX, Song JC, Shi YQ, Liu YX.

Zhonghua Bing Li Xue Za Zhi. 2012 Nov;41(11):733-6. doi: 10.3760/cma.j.issn.0529-5807.2012.11.005. Chinese.

PMID:
23302332
10.

Improved survival with an intact DNA mismatch repair system in endometrial cancer.

Cohn DE, Frankel WL, Resnick KE, Zanagnolo VL, Copeland LJ, Hampel H, Kelbick N, Morrison CD, Fowler JM.

Obstet Gynecol. 2006 Nov;108(5):1208-15.

PMID:
17077244
11.

Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer.

Bruegl AS, Djordjevic B, Batte B, Daniels M, Fellman B, Urbauer D, Luthra R, Sun C, Lu KH, Broaddus RR.

Cancer Prev Res (Phila). 2014 Jul;7(7):686-97. doi: 10.1158/1940-6207.CAPR-13-0359. Epub 2014 Apr 25.

12.

Correlation between patient weight and defects in DNA mismatch repair: is this the link between an increased risk of previous cancer in thinner women with endometrial cancer?

Cohn DE, Pavelka JC, Frankel WL, Morrison CD, Hampel H, Copeland LJ, Fowler JM.

Int J Gynecol Cancer. 2008 Jan-Feb;18(1):136-40. Epub 2007 Apr 26.

PMID:
17466051
13.

Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.

Rabban JT, Calkins SM, Karnezis AN, Grenert JP, Blanco A, Crawford B, Chen LM.

Am J Surg Pathol. 2014 Jun;38(6):793-800. doi: 10.1097/PAS.0000000000000177.

PMID:
24503759
14.

Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability.

Aysal A, Karnezis A, Medhi I, Grenert JP, Zaloudek CJ, Rabban JT.

Am J Surg Pathol. 2012 Feb;36(2):163-72. doi: 10.1097/PAS.0b013e31823bc434.

PMID:
22189970
15.

MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome.

Nelson GS, Pink A, Lee S, Han G, Morris D, Ogilvie T, Duggan MA, Köbel M.

Gynecol Oncol. 2013 Nov;131(2):309-14. doi: 10.1016/j.ygyno.2013.08.003. Epub 2013 Aug 11.

PMID:
23938375
16.

[Analysis of the relationship of DNA mismatch repair with clinicopathologic features and prognosis of colon cancer].

Qin Q, Ying J, Lyu N, Guo L, Zhi W, Zhou A, Wang J.

Zhonghua Zhong Liu Za Zhi. 2015 Aug;37(8):591-6. Chinese.

PMID:
26714599
17.

Lack of association between deficient mismatch repair expression and outcome in endometrial carcinomas of the endometrioid type.

Ruiz I, Martín-Arruti M, Lopez-Lopez E, Garcia-Orad A.

Gynecol Oncol. 2014 Jul;134(1):20-3. doi: 10.1016/j.ygyno.2014.04.053. Epub 2014 May 9.

PMID:
24814467
18.

Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas.

McConechy MK, Talhouk A, Li-Chang HH, Leung S, Huntsman DG, Gilks CB, McAlpine JN.

Gynecol Oncol. 2015 May;137(2):306-10. doi: 10.1016/j.ygyno.2015.01.541. Epub 2015 Jan 28.

PMID:
25636458
19.

[Recent advances and future development on Lynch syndrome-associated endometrial cancer].

Ning Y, Wang Y, Wang YY, Zheng WX.

Zhonghua Bing Li Xue Za Zhi. 2013 Aug;42(8):505-8. Chinese. No abstract available.

PMID:
24246913
20.

Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy.

Warrier SK, Trainer AH, Lynch AC, Mitchell C, Hiscock R, Sawyer S, Boussioutas A, Heriot AG.

Dis Colon Rectum. 2011 Dec;54(12):1480-7. doi: 10.1097/DCR.0b013e318231db1f.

PMID:
22067175

Supplemental Content

Support Center